SciBase submits request for payment rate to NGS
STOCKHOLM, SWEDEN, — December 22, 2021 – SciBase Holding AB (“SciBase”) [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders, announced today that a request for an appropriate Medicare payment assignment for the Nevisense procedure has been submitted to “National Government Services” (NGS), the Medicare Administrative Contractor with carrier jurisdiction responsibility for New York and several other states.In July 2021, the American Medical Association (AMA) assigned a Category III CPT[® ]code for the Nevisense melanoma detection test that has been